CHECKMATE PHARMACEUTICALS IN(NASDAQ:CMPI) stock News

CMPI Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: Checkmate Pharmaceuticals Inc.

University of Iowa Holden Comprehensive Cancer Center Presents Preliminary Data from Clinical Trial of Vidutolimod at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

3 years ago - By: Kahn Swick & Foti, LLC

CHECKMATE PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI

3 years ago - By: Checkmate Pharmaceuticals Inc.

Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update

3 years ago - By: Invezz

Here is why Checkmate shares surged 300%

3 years ago - By: InvestorPlace - Mentions: ARQQ ACC

Why Is Arqit Quantum (ARQQ) Stock Down Today?

3 years ago - By: Benzinga - Mentions: REGN

Checkmate Pharma Shares Skyrocket Over 300% On Regeneron $250M Acquisition Deal

3 years ago - By: Kahn Swick & Foti, LLC

CHECKMATE PHARMACEUTICALS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI

3 years ago - By: Benzinga - Mentions: ALKS ABBV ALNY CHRS ...

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More

3 years ago - By: Weiss Law - Mentions: REGN

SHAREHOLDER ALERT: Weiss Law Investigates Checkmate Pharmaceuticals, Inc.

3 years ago - By: InvestorPlace - Mentions: REGN ACC TWTR

Why Is Checkmate Pharmaceuticals (CMPI) Stock Up 300% Today?

3 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Checkmate Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Regeneron

3 years ago - By: Halper Sadeh LLP

CMPI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Checkmate Pharmaceuticals, Inc. Is Fair to Shareholders

3 years ago - By: Regeneron Pharmaceuticals, Inc. - Mentions: REGN

Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types

3 years ago - By: Checkmate Pharmaceuticals Inc.

Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types

3 years ago - By: Checkmate Pharmaceuticals Inc.

Checkmate Pharmaceuticals Presents Clinical Trial Biomarker Data with Vidutolimod at the 2022 American Association for Cancer Research (AACR) Annual Meeting

3 years ago - By: Checkmate Pharmaceuticals Inc.

Checkmate Pharmaceuticals Announces Full Year 2021 Financial Results and Provides Business Update

4 years ago - By: Checkmate Pharmaceuticals Inc.

CHECKMATE PHARMACEUTICALS IN (CMPI) Stock News

CMPI Latest News, Press Relases and Analysis

University of Iowa Holden Comprehensive Cancer Center Presents Preliminary Data from Clinical Trial of Vidutolimod at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

CHECKMATE PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI

Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update

Here is why Checkmate shares surged 300%

Why Is Arqit Quantum (ARQQ) Stock Down Today?

Checkmate Pharma Shares Skyrocket Over 300% On Regeneron $250M Acquisition Deal

CHECKMATE PHARMACEUTICALS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More

SHAREHOLDER ALERT: Weiss Law Investigates Checkmate Pharmaceuticals, Inc.

Why Is Checkmate Pharmaceuticals (CMPI) Stock Up 300% Today?

Shareholder Alert: Ademi LLP investigates whether Checkmate Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Regeneron

CMPI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Checkmate Pharmaceuticals, Inc. Is Fair to Shareholders

Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types

Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types

Checkmate Pharmaceuticals Presents Clinical Trial Biomarker Data with Vidutolimod at the 2022 American Association for Cancer Research (AACR) Annual Meeting

Checkmate Pharmaceuticals Announces Full Year 2021 Financial Results and Provides Business Update

Checkmate Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual Meeting